| pubmed-article:65217 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0012155 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0000248 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0036002 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:65217 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:65217 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:65217 | pubmed:dateCreated | 1977-4-15 | lld:pubmed |
| pubmed-article:65217 | pubmed:abstractText | Hepatic levels of S-adenosylmethionine (AdoMet), of glutathione, and of the microsomal enzymes p-nitroanisole demethylase and benzo(a)pyrene hydroxylase were measured in male and female rats fed a diet marginally deficient in choline and methionine and void of folic acid (lipotrope deficient) or an adequate diet for 0 to 14 weeks with and without added 2-acetylaminofluorene (AAF). The urinary metabolites of AAF were determined throughout the experimental period. After 2 to 4 weeks of dietary administration, the hepatic AdoMet levels were 43% lower in male rats fed the lipotrope-deficient diet than in male rats fed the lipotrope-adequate diet; no differences were found in hepatic AdoMet of females fed the lipotrope-deficient or lipotrope-adequate diets for 2 to 14 weeks. Administration of AAF to lipotrope-deficient female rats for 2 weeks led to a transient decrease in hepatic levels of AdoMet. The administration of AAF for 2 to 14 weeks did not significantly affect hepatic AdoMet in female rats fed the lipotrope-adequate diet or in male rats fed either diet. Female rats fed the lipotrope-deficient diet and treated with AAF excreted decreased proportions of N-hydroxy-2-acetylaminofluorene and increased proportions of 5-hydroxy-2-acetylaminofluorene in their urine. However, the urine of lipotrope-deficient male rats treated with AAF contained increased proportions of N-hydroxy-2-acetylaminofluorene and decreased levels of 5-hydroxy-2-acetylaminofluorene. The urinary excretion of 7-hydroxy-2-acetylaminofluorene by male and female lipotrope-deficient rats treated with AAF was generally similar to that in lipotrope-adequate rats. The lipotrope-deficient diet did not appear to alter the hepatic levels of glutathione, p-nitroanisole demethylase, or benzo(a)pyrene hydroxylase activity was lower in the livers of lipotrope-deficient male rats treated with AAF for 8 to 14 weeks than in the livers of lipotrope-deficient rats not receiving the carcinogen. The altered metabolism of AAF correlated well with the previously reported effects of a marginal lipotrope deficiency on AAF carcinogenesis. | lld:pubmed |
| pubmed-article:65217 | pubmed:language | eng | lld:pubmed |
| pubmed-article:65217 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:65217 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:65217 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:65217 | pubmed:issn | 0008-5472 | lld:pubmed |
| pubmed-article:65217 | pubmed:author | pubmed-author:GranthamP HPH | lld:pubmed |
| pubmed-article:65217 | pubmed:author | pubmed-author:PoirierL ALA | lld:pubmed |
| pubmed-article:65217 | pubmed:author | pubmed-author:RogersA EAE | lld:pubmed |
| pubmed-article:65217 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:65217 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:65217 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:65217 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:65217 | pubmed:pagination | 744-8 | lld:pubmed |
| pubmed-article:65217 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-An... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Se... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Di... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Li... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Ra... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Fl... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Me... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Ch... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Gl... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Li... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Fe... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Ma... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Fo... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Mi... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Be... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-S-... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-2-... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Ni... | lld:pubmed |
| pubmed-article:65217 | pubmed:meshHeading | pubmed-meshheading:65217-Hy... | lld:pubmed |
| pubmed-article:65217 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:65217 | pubmed:articleTitle | The effects of a marginally lipotrope-deficient diet on the hepatic levels of S-adenosylmethionine and on the urinary metabolites of 2-acetylaminofluorene in rats. | lld:pubmed |
| pubmed-article:65217 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:65217 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:65217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:65217 | lld:pubmed |
